以肺结核为先兆的慢性髓系白血病
Chronic Myeloid Leukemia Preceded by Tuberculosis.
作者信息
Al-Qudah Bara M, Yassin Mohamed A, Abdulla Mohammad A J, Aldapt Mahmood S, Abufaied Mohamad M
机构信息
Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
出版信息
Case Rep Oncol. 2020 Jun 24;13(2):708-711. doi: 10.1159/000507822. eCollection 2020 May-Aug.
Abstract
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm, classically described as a triphasic disease. However, little is known about risk factors for developing CML. Currently, ionizing radiation is the only established risk factor. Here, we report on a 37-year-old man treated for tuberculosis; 2 years later, he developed CML in a chronic phase. We would like to shed light on tuberculosis as a possible risk factor for CML.
摘要
慢性髓性白血病（CML）是一种骨髓增殖性肿瘤，传统上被描述为一种三相性疾病。然而，对于CML发生的危险因素知之甚少。目前，电离辐射是唯一已确定的危险因素。在此，我们报告一名37岁接受过结核病治疗的男性；2年后，他进入慢性期CML。我们希望阐明结核病作为CML一种可能危险因素的情况。
相似文献
1
Chronic Myeloid Leukemia Preceded by Tuberculosis.以肺结核为先兆的慢性髓系白血病
Case Rep Oncol. 2020 Jun 24;13(2):708-711. doi: 10.1159/000507822. eCollection 2020 May-Aug.
2
Ophthalmologic Manifestations as Initial Presentation of Patients with Chronic Myeloid Leukemia: Report of Two Cases.慢性髓性白血病患者以眼科表现为首发症状：2例报告
Case Rep Oncol. 2020 Jan 20;13(1):7-11. doi: 10.1159/000504928. eCollection 2020 Jan-Apr.
3
Risk and impact of tuberculosis in patients with chronic myeloid leukemia: a nationwide population-based study in Taiwan.慢性粒细胞白血病患者结核病的风险与影响：台湾一项基于全国人口的研究
Int J Cancer. 2015 Apr 15;136(8):1881-7. doi: 10.1002/ijc.29201. Epub 2014 Sep 30.
4
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.混合表型（T/B/髓系）髓外原始细胞危象作为慢性髓性白血病的初始表现。
Exp Mol Pathol. 2018 Apr;104(2):130-133. doi: 10.1016/j.yexmp.2018.02.005. Epub 2018 Mar 1.
5
[Indication for surgery in a patient with tuberculoma accompanied by chronic myeloid leukemia].[伴有慢性髓性白血病的结核瘤患者的手术指征]
Kyobu Geka. 1990 Nov;43(12):1009-11.
6
Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase.伊马替尼致慢性期慢性髓性白血病患者震颤
Case Rep Oncol. 2019 Dec 9;12(3):913-917. doi: 10.1159/000504937. eCollection 2019 Sep-Dec.
7
Current perspectives for the treatment of chronic myeloid leukemia.慢性髓性白血病治疗的现状。
Turk J Med Sci. 2019 Feb 11;49(1):1-10. doi: 10.3906/sag-1810-81.
8
Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia.
Pathology. 1988 Jan;20(1):1-6. doi: 10.3109/00313028809085187.
9
Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.同一患者患三种血液系统恶性肿瘤：慢性淋巴细胞白血病，继之慢性髓系白血病和急性髓系白血病。
Clin Lab. 2014;60(11):1929-32. doi: 10.7754/clin.lab.2014.140315.
10
A Case of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia, Chronic Phase with ASXL1 Mutation.1例伴有ASXL1突变的酪氨酸激酶抑制剂耐药慢性期慢性髓性白血病病例
Case Rep Oncol. 2020 Apr 22;13(1):449-455. doi: 10.1159/000506452. eCollection 2020 Jan-Apr.
引用本文的文献
1
Cervical Lymphadenopathy in Concomitant CML and Tuberculosis: A Case Report.慢性粒细胞白血病合并肺结核时的颈部淋巴结病：一例报告
Case Rep Oncol. 2025 May 20;18(1):751-755. doi: 10.1159/000546368. eCollection 2025 Jan-Dec.
本文引用的文献
1
MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.MERGE：亚洲、中东、土耳其和阿尔及利亚的骨髓增殖性肿瘤多国多中心观察性注册研究。
Cancer Med. 2020 Jul;9(13):4512-4526. doi: 10.1002/cam4.3004. Epub 2020 Apr 30.
2
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries.目标：对 33 个国家慢性髓性白血病的真实世界管理进行调查。
Br J Haematol. 2020 Sep;190(6):869-876. doi: 10.1111/bjh.16599. Epub 2020 Mar 30.
3
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.β-连环蛋白和蛋白酪氨酸受体型 γ 在慢性髓性白血病中的调控环路。
Int J Mol Sci. 2020 Mar 26;21(7):2298. doi: 10.3390/ijms21072298.
4
Autoimmune Hemolytic Anemia After Relapse of Chronic Myeloid Leukemia: A Case Report.慢性髓性白血病复发后自身免疫性溶血性贫血：一例报告
Clin Med Insights Blood Disord. 2019 Dec 23;12:1179545X19894578. doi: 10.1177/1179545X19894578. eCollection 2019.
5
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients.一种新型单克隆抗体可检测慢性髓性白血病患者中γ型蛋白酪氨酸磷酸酶受体的下调。
J Hematol Oncol. 2017 Jun 21;10(1):129. doi: 10.1186/s13045-017-0494-z.
6
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?卡塔尔慢性髓性白血病患者对甲磺酸伊马替尼治疗的依从性是否与更好的临床结果相关？
Clin Med Insights Oncol. 2016 Oct 2;10:95-104. doi: 10.4137/CMO.S32822. eCollection 2016.
7
Studying the Impact of Presence of Alpha Acid Glycoprotein and Protein Glycoprotein in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate in the State of Qatar.研究α酸性糖蛋白和蛋白糖蛋白的存在对卡塔尔接受甲磺酸伊马替尼治疗的慢性髓性白血病患者的影响。
Biomark Cancer. 2015 Nov 29;7:63-7. doi: 10.4137/BIC.S31427. eCollection 2015.
8
Risk and impact of tuberculosis in patients with chronic myeloid leukemia: a nationwide population-based study in Taiwan.慢性粒细胞白血病患者结核病的风险与影响：台湾一项基于全国人口的研究
Int J Cancer. 2015 Apr 15;136(8):1881-7. doi: 10.1002/ijc.29201. Epub 2014 Sep 30.
9
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.欧洲形态亚型血液系统恶性肿瘤的发病率：HAEMACARE 项目的结果。
Blood. 2010 Nov 11;116(19):3724-34. doi: 10.1182/blood-2010-05-282632. Epub 2010 Jul 27.
10
The biology of chronic myeloid leukemia.慢性髓性白血病的生物学
N Engl J Med. 1999 Jul 15;341(3):164-72. doi: 10.1056/NEJM199907153410306.
Zotero 插件